Qbrexza
Active Ingredient(s): Glycopyrronium TosylateFDA Approved: * June 28, 2018
Pharm Company: * DERMIRA INC
Category: Anticholinergic
Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is available in oral, intravenous, topical, and inhaled forms. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by the FDA to treat excessive underarm sweating,... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.